(Q40666128)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12620690%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

title

5-Fluorouracil-cisplatin adducts with potential antitumor activity (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12620690%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12620690%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

author name string

Jun Lin

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12620690%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Xianming Zhang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12620690%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Qin Liu

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12620690%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Qiang Xu

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12620690%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Ren-Xiang Tan

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12620690%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Zijian Guo

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12620690%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

publication date

1 February 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12620690%20AND%20SRC:MED&resulttype=core&format=json

Journal of Inorganic Biochemistry

1 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12620690%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

volume

94

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12620690%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12620690%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

page(s)

186-192

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12620690%20AND%20SRC:MED&resulttype=core&format=json

A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a Mid-Atlantic Oncology Program Study

1 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2802%2900618-9

7 January 2021

Basis for effective combination cancer chemotherapy with antimetabolites

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2802%2900618-9

7 January 2021

Biochemical modification of the toxicity and the anti-tumour effect of 5-fluorouracil and cis-platinum by WR-2721 in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2802%2900618-9

7 January 2021

Current role of chemotherapy in head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2802%2900618-9

7 January 2021

Superior clinical response and survival rates with initial bolus of cisplatin and 120 hour infusion of 5-fluorouracil before definitive therapy for locally advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2802%2900618-9

7 January 2021

Improved complete response rate and survival in advanced head and neck cancer after three-course induction therapy with 120-hour 5-FU infusion and cisplatin.

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2802%2900618-9

7 January 2021

Evaluation of high-dose cisplatin and 5-FU infusion as initial therapy in advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2802%2900618-9

7 January 2021

Response rates and survival in patients with head and neck cancer treated with a combination of cisplatin and 5-fluorouracil prior to radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2802%2900618-9

7 January 2021

Neoadjuvant chemotherapy with cisplatin and 5-fluorouracil, both in continuous 96-hour infusion, in the treatment of locally advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2802%2900618-9

7 January 2021

Randomized trial of neoadjuvant chemotherapy with cisplatin plus 5-fluorouracil, with or without leucovorin, in locally advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2802%2900618-9

7 January 2021

Low-dose continuous infusion 5-fluorouracil and cisplatin: phase II evaluation in advanced colorectal carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2802%2900618-9

7 January 2021

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2802%2900618-9

7 January 2021

Chemical and biological properties of a new series of cis-diammineplatinum(II) antitumor agents containing three nitrogen donors: cis-[Pt(NH3)2(N-donor)Cl]+

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2802%2900618-9

7 January 2021

10.1016/S0162-0134(02)00618-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12620690%20AND%20SRC:MED&resulttype=core&format=json

release_dbvwdnfa3fg5nnojlj5bll3fpy

1 November 2019

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/dbvwdnfa3fg5nnojlj5bll3fpy

24 November 2022

mapped directly with Wikidata item

1 reference